CCL3L1 and HIV/AIDS Susceptibility

Authors

• Thomas J. Urban, Duke University
• Amy C. Weintrob, Walter Reed Army Medical Center; Uniformed Services University of the Health Sciences
• Jacques Fellay, Duke University
• Sara Colombo, University of Lausanne - Switzerland
• Kevin V. Shianna, Duke University
• Curtis Gumbs, Duke University
• Margalida Rotger, University of Lausanne - Switzerland
• Kimberly Pelak, Duke University
• Kristen K. Dang, Duke University
• Roger Detels, University of California - Los Angeles; Multicenter AIDS Cohort Study
• Jeremy J. Martinson, University of Pittsburgh; Multicenter AIDS Cohort Study
• Stephen J. O'Brien, National Cancer Institute at FrederickFollow
• Norman L. Letvin, Harvard Medical School
• Andrew J. McMichael, John Radcliffe Hospital - United Kingdom
• Barton F. Haynes, Duke University
• Mary Carrington, National Cancer Institute at Frederick
• Amalio Telenti, University of Lausanne - Switzerland; Center for HIV/AIDS Vaccine Immunology; Euro-CHAVI Consortia
• Nelson L. Michael, Walter Reed Army Institute of Research; Infectious Disease Clinical Research Program
• David B. Goldstein, Duke University; Center for HIV/AIDS Vaccine Immunology; Euro-CHAVI Consortia

ORCID

0000-0001-7353-8301

ResearcherID

N-1726-2015

Document Type

Article

Publication Title

Nature Medicine

ISSN

1078-8956

Publication Date

10-1-2009

Volume

15

Issue

10

First Page

1110

Last Page

1112

Comments

©2009 Nature Publishing Group

Additional Comments

National Cancer Institute contract #: N01-CO-12400

NSUWorks Citation

Urban, Thomas J.; Amy C. Weintrob; Jacques Fellay; Sara Colombo; Kevin V. Shianna; Curtis Gumbs; Margalida Rotger; Kimberly Pelak; Kristen K. Dang; Roger Detels; Jeremy J. Martinson; Stephen J. O'Brien; Norman L. Letvin; Andrew J. McMichael; Barton F. Haynes; Mary Carrington; Amalio Telenti; Nelson L. Michael; and David B. Goldstein. 2009. "CCL3L1 and HIV/AIDS Susceptibility." Nature Medicine 15, (10): 1110-1112. https://nsuworks.nova.edu/cnso_bio_facarticles/473